Accessibility Menu
 
Arrow-Thin-Down
S&P 500
6,477.16
-1.7%
-114.74
Arrow-Thin-Down
DJI
45,960.11
-1.0%
-469.38
Arrow-Thin-Down
NASDAQ
21,408.08
-2.4%
-521.74
Arrow-Thin-Down
Bitcoin
$68,687.00
-3.7%
-$2,615.29
Arrow-Thin-Down
AMZN
$207.55
-2.0%
-$4.16
Arrow-Thin-Down
GOOG
$280.74
-3.1%
-$8.85
Arrow-Thin-Down
META
$547.32
-8.0%
-$47.57
Arrow-Thin-Down
MSFT
$365.86
-1.4%
-$5.18
Arrow-Thin-Down
NVDA
$171.28
-4.1%
-$7.40
Arrow-Thin-Down
TSLA
$372.24
-3.6%
-$13.71
Most Active StocksDaily Stock GainersDaily Stock Losers

Why Hims & Hers Stock Jumped on Massive FDA News

Shares of Hims & Hers were on fire Monday because the FDA's new leader seems to be a fan of the company's business model.

By Travis Hoium – Nov 26, 2024 at 12:07PM EST

Shares of Hims & Hers (HIMS 0.29%) jumped as much as 23% in trading on Monday after President Trump announced his new Food and Drug Administration (FDA) chief, who happens to have ties to a business similar to Hims & Hers. In this video, Travis Hoium covers why this is important and why the stock is moving as fast as it is.

*Stock prices used were end-of-day prices of Nov. 25, 2024. The video was published on Nov. 25, 2024.

Read Next

About the Author

Travis Hoium
Travis Hoium is a contributing Motley Fool stock market analyst covering solar energy, technology, and growth stocks. Before The Motley Fool, Travis was a mechanical engineer at 3M and founded a virtual reality company. He holds a bachelor’s degree in mechanical engineering and a master’s degree in business administration from the University of Minnesota.
TMFFlushDraw
X@travishoium

Travis Hoium has positions in Hims & Hers Health. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Travis Hoium is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link, they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.

Stocks Mentioned

Hims & Hers Health Stock Quote
Hims & Hers Health
NYSE: HIMS
$20.78
(-0.29%)-$0.06

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services